A multidrug-resistant Acinetobacter baumannii outbreak in intensive care unit: antimicrobial and organizational
Guglielmo Consales1, Elena Gramigni1, Lucia Zamidei2
1Anaesthesia and Intensive Care Unit, Misericordia e Dolce Hospital, piazza dell'Ospedale 5, 59100 Prato, Italy.
Purpose:
Multidrug-resistant Acinetobacter baumannii (MRAB) is an emerging cause of intensive care unit (ICU) outbreaks. Patients are the main reservoirs, inducing cross transmission. We describe an MRAB outbreak that occurred in the Prato Hospital ICU in June to August 2009.
Materials And Methods:
The ICU consists of 2 separated 4-bed rooms (rooms A and B). The MRAB-positive patients were included in our study. During the outbreak, infection control measures were enhanced; patients and environmental screenings were performed. A 6-month follow-up was carried out.
Results:
Four of 26 patients admitted during the outbreak were MRAB positive. All patients were located in room A; no case was detected in room B either in the hospital or during the follow-up. Management included closure to new admissions, reinforcement of infection control measures, patient and environmental screenings, discharge of room B MRAB-negative patients for at least 5 days after the first case identification. All isolates were carbapenems resistant and tigecycline and colistin susceptible. All patients received tigecycline: 2 were successfully treated, 1 died because of preexisting illness, and 1 developed resistance and recovered after colistin therapy.
Conclusions:
Enhanced infection control measures and adequate antibiotic strategy limited the outbreak. Tigecycline allowed rapid recovery. Nevertheless, resistance ensued; so colistin remained the only therapeutic option. However, pan-drug resistance has been reported.
Insights
An Acinetobacter baumannii outbreak in an ICU was controlled with enhanced infection measures and tigecycline. Colistin was needed when resistance developed, highlighting the threat of pan-drug resistance.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Multidrug-resistant Acinetobacter baumannii (MRAB) poses a significant threat in intensive care units (ICUs).
- Patient-to-patient transmission is a primary driver of MRAB outbreaks.
- This study details an MRAB outbreak in a hospital ICU.
Purpose of the Study:
- To describe and analyze an MRAB outbreak in an ICU setting.
- To evaluate the effectiveness of infection control measures during the outbreak.
- To assess antibiotic treatment strategies for MRAB infections.
Main Methods:
- The study included MRAB-positive patients in a 2-room ICU.
- Enhanced infection control protocols were implemented, including patient and environmental screening.
- A 6-month follow-up was conducted to monitor for recurrence.
Main Results:
- Four out of 26 patients were identified as MRAB positive, all located in one room.
- No MRAB cases were detected in the second room or during follow-up.
- Isolates were resistant to carbapenems but susceptible to tigecycline and colistin; tigecycline treatment was successful for two patients, with one developing resistance and requiring colistin.
Conclusions:
- Enhanced infection control and appropriate antibiotic use successfully limited the MRAB outbreak.
- Tigecycline facilitated rapid recovery, but subsequent resistance necessitates colistin.
- The emergence of pan-drug resistance remains a critical concern in managing MRAB infections.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Clinical Significance of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management
Mechanism of Antibiotic Resistance in MRSA
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Antimicrobial Effectiveness
